Skip to main content
NIH funding notice PA-16-076

Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01)

Closed on January 24, 2018.

Posted
January 8, 2016
Close date
January 24, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $693,537 in first-year total cost, median $693,537.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BST-X (02)]1

Most frequent institutions

  1. UNIVERSITY OF PENNSYLVANIA1
Competing awards under PA-16-076 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Development of a Point-of-Care Volumetric Bar-Chart Chip for Drug Quantitation2R01DA035868-04A1QIN, LIDONGWANG, PINGUNIVERSITY OF PENNSYLVANIA, PA$693,537ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.